Synergistic Impact of Xanthorrhizol and d-δ-Tocotrienol on the Proliferation of Murine B16 Melanoma Cells and Human DU145 Prostate Carcinoma Cells

References

• Oon SF, Nallappan M, Tee TT, Shohaimi S, Kassim NK, Sa'ariwijaya MSF, Cheah YH. Xanthorrhizol: a review of its pharmacological activities and anticancer properties. Cancer Cell Int. 2015;15:100. doi:10.1186/s12935-015-0255-4
   PubMed Web of Science ®Google Scholar
• Cheah YH, Nordin FJ, Tee TT, Azimahtol HLP, Abdullah NR, Ismail Z. Antiproliferative property and apoptotic effect of xanthorrhizol on MDA-MB-231 breast cancer cells. Anticancer Res. 2008;28(6A):3677–89. doi:10.1186/1475-2867-9-1
   PubMed Web of Science ®Google Scholar
• Cheah YH, Azimahtol HLP, Abdullah NR. Xanthorrhizol exhibits antiproliferative activity on MCF-7 breast cancer cells via apoptosis induction. Anticancer Res. 2006;26(6B):4527–34.
   PubMed Web of Science ®Google Scholar
• Ismail N, Pihie AHL, Nallapan M. Xanthorrhizol induces apoptosis via the up-regulation of Bax and p53 in HeLa cells. Anticancer Res. 2005;25(3B):2221–7.
   PubMed Web of Science ®Google Scholar
• Kang YJ, Park KK, Chung WY, Hwang JK, Lee SK. Xanthorrhizol, a natural sesquiterpenoid, induces apoptosis and growth arrest in HCT116 human colon cancer cells. J Pharmacol Sci. 2009;111(3):276–84. doi:10.1254/jphs.09141fp
   PubMed Web of Science ®Google Scholar
• Itokawa H, Hirayama F, Funakoshi K, Takeya K. Studies on the antitumor bisabolane sesquiterpenoids isolated from Curcuma xanthorrhiza. Chem Pharm Bull. 1985;33(8):3488–92. doi:10.1248/cpb.33.3488
   PubMed Web of Science ®Google Scholar
• Choi MA, Kim SH, Chung WY, Hwang JK, Park KK. Xanthorrhizol, a natural sesquiterpenoid from Curcuma xanthorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Biochem Biophys Res Commun. 2005;326(1):210–7. doi:10.1016/j.bbrc.2004.11.020
   PubMed Web of Science ®Google Scholar
• Cheah YH, Nordin FJ, Sarip R, Tee TT, Azimahtol HLP, Sirat HM, Rashid BAA, Abdullah NR, Ismail Z. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int. 2009;9:1. doi:10.1186/1475-2867-9-1
   PubMed Web of Science ®Google Scholar
• Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood)). 2004;229(7):567–85. doi:10.1177/153537020422900701
   PubMed Web of Science ®Google Scholar
• Fernandes NV, Yeganehjoo H, Katuru R, DeBose-Boyd RA, Morris LL, Michon R, Yu Z-L, Mo H. Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase. Exp Biol Med (Maywood)). 2013;238(11):1265–74. doi:10.1177/1535370213492693
   PubMed Web of Science ®Google Scholar
• Katuru R, Fernandes NV, Elfakhani M, Dutta D, Mills N, Hynds DL, King C, Mo H. Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells. Exp Biol Med (Maywood)). 2011;236(5):604–13. doi:10.1258/ebm.2011.010379
   PubMed Web of Science ®Google Scholar
• Sever N, Song B-L, Yabe D, Goldstein JL, Brown MS, DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem. 2003;278(52):52479–90. doi:10.1074/jbc.M310053200
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim C, Kim S-H, Sethi G, Ahn KS. Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway. Cancer Lett. 2015;360(2):280–93. doi:10.1016/j.canlet.2015.02.024
   PubMed Web of Science ®Google Scholar
• Ansari M, Emami S. β-Ionone and its analogs as promising anticancer agents . Eur J Med Chem. 2016;123:141–54. doi:10.1016/j.ejmech.2016.07.037
   PubMed Web of Science ®Google Scholar
• Liu W, Furuta E, Shindo K, Watabe M, Xing F, Pandey PR, Okuda H, Pai SK, Murphy LL, Cao D, et al. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Breast Cancer Res Treat. 2011;128(1):57–68.: doi:10.1007/s10549-010-1076-8
   PubMed Web of Science ®Google Scholar
• Mo H, Elson CE. Role of the mevalonate pathway in tocotrienol-mediated tumor suppression. In: Tocotrienols: vitamin E beyond tocopherols. Boca Raton: CRC Press; 2008. p. 185–207.
   Google Scholar
• Mo H, Elfakhani M, Shah A, Yeganehjoo H. Mevalonate-suppressive tocotrienols for cancer chemoprevention and adjuvant therapy. In: Tocotrienols: vitamin E beyond tocopherols. (2nd ed.). Boca Raton: CRC Press:; 2013. p. 135–49.
   Google Scholar
• Constantinou C, Charalambous C, Kanakis D. Vitamin E and cancer: an update on the emerging role of gamma and delta tocotrienols. Eur J Nutr. 2020;59(3):845–57. doi:10.1007/s00394-019-01962-1
   PubMed Web of Science ®Google Scholar
• Montagnani Marelli M, Marzagalli M, Fontana F, Raimondi M, Moretti RM, Limonta P. Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets. J Cell Physiol. 2019;234(2):1147–64. doi:10.1002/jcp.27075
   PubMed Web of Science ®Google Scholar
• Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169(3):381–405. doi:10.1016/j.cell.2017.04.001
   PubMed Web of Science ®Google Scholar
• Mo H, Jeter R, Backmann A, Yount ST, Shen CL, et al. The potential of isoprenoids in adjuvant cancer therapy to reduce adverse effects of statins. Front Pharmacol. 2019;9:1515.doi:10.3389/fphar.2018.01515
   Web of Science ®Google Scholar
• Yeganehjoo H, DeBose-Boyd R, McFarlin BK, Mo H. Synergistic impact of d-δ-tocotrienol and geranylgeraniol on the growth and HMG CoA reductase of human DU145 prostate carcinoma cells. Nutr Cancer. 2017;69(4):682–91. doi:10.1080/01635581.2017.1299876
   PubMed Web of Science ®Google Scholar
• Tallarida RJ. An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther. 2006;319(1):1–7. doi:10.1124/jpet.106.104117
   PubMed Web of Science ®Google Scholar
• Massague J. G1 cell-cycle control and cancer. Nature. 2004;432:298–306.
   PubMed Web of Science ®Google Scholar
• McAnally JA, Gupta J, Sodhani S, Bravo L, Mo H. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp Biol Med (Maywood)). 2007;232(4):523–31.
   PubMed Web of Science ®Google Scholar
• Constantinou C, Neophytou CM, Vraka P, Hyatt JA, Papas KA, Constantinou AI. Induction of DNA damage and caspase-independent programmed cell death by vitamin E. Nutr Cancer. 2012;64(1):136–52. doi:10.1080/01635581.2012.630167
   PubMed Web of Science ®Google Scholar
• Jones S, Fernandes NV, Yeganehjoo H, Katuru R, Qu H, Yu Z, Mo H. β-Ionone induces cell cycle arrest and apoptosis in human prostate tumor cells. Nutr Cancer. 2013;65(4):600–10. doi:10.1080/01635581.2013.776091
   PubMed Web of Science ®Google Scholar
• Handayani T, Sakinah S, Nallappan M, Pihie AHL. Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells. Anticancer Res. 2007;27(2):965–71.
   PubMed Web of Science ®Google Scholar
• Luk SU, Yap WN, Chiu Y-T, Lee DTW, Ma S, Lee TKW, Vasireddy RS, Wong Y-C, Ching YP, Nelson C, et al. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer. 2011;128(9):2182–91. doi:10.1002/ijc.25546
   PubMed Web of Science ®Google Scholar
• Fernandes NV, Guntipalli PK, Mo H. d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. Anticancer Res. 2010;30(12):4937–44.
   PubMed Web of Science ®Google Scholar
• Conte C, Floridi A, Aisa C, Piroddi M, Floridi A, Galli F. Galli F: γ-Tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann N Y Acad Sci. 2004;1031(1):391–4. doi:10.1196/annals.1331.054
   PubMed Web of Science ®Google Scholar
• Odysseos AD, Vraka P, Bouralexis S, Frindlay DM, Papas A. γ-Tocotrienol triggers caspase-mediated induction of apoptosis in androgen-responsive, but not androgen unresponsive prostate cancer cells in vitro. Free Radic Res. 2002;36:116–7.
   Web of Science ®Google Scholar
• Srivastava JK, Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun. 2006;346(2):447–53. doi:10.1016/j.bbrc.2006.05.147
   PubMed Web of Science ®Google Scholar
• Mo H, Elson CE. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutr. 1999;129(4):804–13. doi:10.1093/jn/129.4.804
   PubMed Web of Science ®Google Scholar
• He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr. 1997;127(5):668–74. doi:10.1093/jn/127.5.668
   PubMed Web of Science ®Google Scholar
• Tatman D, Mo H. Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells. Cancer Lett. 2002;175(2):129–39. doi:10.1016/s0304-3835(01)00723-6
   PubMed Web of Science ®Google Scholar
• Noomhorm N, Chang C-J, Wen C-S, Wang J-Y, Chen J-L, Tseng L-M, Chen W-S, Chiu J-H, Shyr Y-M. In vitro and in vivo effects of xanthorrhizol on human breast cancer MCF-7 cells treated with Tamoxifen. J Pharmacol Sci. 2014;125(4):375–85. doi:10.1254/jphs.14024fp
   PubMed Web of Science ®Google Scholar
• Dronamraju V, Ibrahim BA, Briski KP, Sylvester PW. γ-tocotrienol suppression of the warburg effect is mediated by AMPK activation in human breast cancer cells . Nutr Cancer. 2019;71(7):1214–28. doi:10.1080/01635581.2019.1599969
   PubMed Web of Science ®Google Scholar
• Algayadh IG, Dronamraju V, Sylvester PW. Role of Rac1/WAVE2 signaling in mediating the inhibitory effects of γ-tocotrienol on mammary cancer cell migration and invasion. Biol Pharm Bull. 2016;39(12):1974–82. doi:10.1248/bpb.b16-00461
   PubMed Web of Science ®Google Scholar
• Ahmed RA, Alawin OA, Sylvester PW. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling. Cell Prolif. 2016;49(4):460–70. doi:10.1111/cpr.12270
   PubMed Web of Science ®Google Scholar
• Husain K, Francois RA, Yamauchi T, Perez M, Sebti SM, Malafa MP. Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer . Mol Cancer Ther. 2011;10(12):2363–72. doi:10.1158/1535-7163.MCT-11-0424
   PubMed Web of Science ®Google Scholar
• Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SAG, Krishnan K. Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radic Biol Med. 2011;51(6):1164–74. doi:10.1016/j.freeradbiomed.2011.06.008
   PubMed Web of Science ®Google Scholar
• Yap WN, Chang PN, Han HY, Lee DTW, Ling MT, Wong YC, Yap YL. Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. Br J Cancer. 2008;99(11):1832–41. doi:10.1038/sj.bjc.6604763
   PubMed Web of Science ®Google Scholar
• Kim JY, An JM, Chung W-Y, Park K-K, Hwang JK, Kim DS, Seo SR, Seo JT. Xanthorrhizol induces apoptosis through ROS-mediated MAPK activation in human oral squamous cell carcinoma cells and inhibits DMBA-induced oral carcinogenesis in hamsters. Phytother Res. 2013;27(4):493–8. doi:10.1002/ptr.4746
   PubMed Web of Science ®Google Scholar
• Chung WY, Park JH, Kim MJ, Kim HO, Hwang JK, Lee SK, Park KK. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis. 2007;28(6):1224–31. doi:10.1093/carcin/bgm005
   PubMed Web of Science ®Google Scholar
• Krycer JR, Phan L, Brown AJ. A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products. Biochem J. 2012;446(2):191–201. doi:10.1042/BJ20120545
   PubMed Web of Science ®Google Scholar
• Song BL, DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem. 2006;281(35):25054–61. doi:10.1074/jbc.M605575200
   PubMed Web of Science ®Google Scholar
• Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1993;268(15):11230–8.
   PubMed Web of Science ®Google Scholar
• Pearce BC, Parker RA, Deason ME, Qureshi AA, Wright JJ. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem. 1992;35(20):3595–606. doi:10.1021/jm00098a002
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Burger WC, Peterson DM, Elson CE. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem. 1986;261(23):10544–50.
   PubMed Web of Science ®Google Scholar
• Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y. Dislodgment and accelerated degradation of Ras. Biochemistry. 1998;37(5):1306–14. doi:10.1021/bi972032d
   PubMed Web of Science ®Google Scholar
• Hall RD, Kudchadkar RR. BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies. Cancer Control. 2014;21(3):221–30. doi:10.1177/107327481402100307
   PubMed Web of Science ®Google Scholar
• Groenendijk FH, Bernards R. Drug resistance to targeted therapies: déjà vu all over again. Mol Oncol. 2014;8(6):1067–83. doi:10.1016/j.molonc.2014.05.004
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Khan DA, Saleem S, Silswal N, Trias AM, et al. Pharmacokinetics and Bioavailability of Annatto δ-tocotrienol in Healthy Fed Subjects. J Clin Exp Cardiol. 2015;6:411.:
   Google Scholar
• Mahipal A, Klapman J, Vignesh S, Yang CS, Neuger A, Chen D-T, Malafa MP. Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites . Cancer Chemother Pharmacol. 2016;78(1):157–65. doi:10.1007/s00280-016-3048-0
   PubMed Web of Science ®Google Scholar